/ALVET.PA
ALVET.PA Stock - TheraVet S.A.
Healthcare|BiotechnologyPAR
$0.08+0.00%
+$0.00 (+0.00%) • Jan 27
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.09
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ALVET.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.08 – $0.08
TARGET (TP)$0.09
STOP LOSS$0.08
RISK/REWARD1:4.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.50
52W High$1.10
52W Low$0.06
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $1.08M | $1.60M | $1.94M | $987,809 | $780,644 |
| Gross Profit | $-530,796 | $-992,803 | $-603,557 | $-112,205 | $486 |
| Gross Margin | -49.2% | -62.0% | -31.1% | -11.4% | 0.1% |
| Operating Income | $-2,175,109 | $-2,776,702 | $-1,728,912 | $-401,200.13 | $-95,325.33 |
| Net Income | $-1,570,707 | $-2,363,249 | $-1,340,850 | $-388,463.33 | $-98,932.84 |
| Net Margin | -145.7% | -147.5% | -69.0% | -39.3% | -12.7% |
| EPS | $-0.49 | $-0.73 | $-0.42 | $-0.12 | $-0.03 |
Company Overview
TheraVet SA, a veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States. The company primarily provides products for osteoarthritis, ligament and tendon injuries, and bone surgery in cats, dogs, and horses. It offers BIOCERA-VET for osseointegration and bone remodelling; and VISCO-VET, an injectable visco-regenerative gel based on hyaluronic acid with anti-inflammatory properties that promotes the effect of active components, as well as acts as a cell colonization supporting tissue regeneration. The company was incorporated in 2017 and is headquartered in Jumet, Belgium.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ALVET.PABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.26
Q2 2024
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q4 23
No data
Q2 24
No data
Q2 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 6, 2025 | — | — | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.26 | — | — |
Q2 2024 | Apr 23, 2024 | — | $-0.21 | — | — |
Q4 2023 | Nov 8, 2023 | — | $-0.28 | — | — |
Q2 2023 | Apr 25, 2023 | — | $-0.35 | — | — |
Q4 2022 | Nov 19, 2022 | — | $-0.37 | — | — |
Q2 2022 | Apr 6, 2022 | — | $-0.18 | — | — |
Q4 2021 | Oct 26, 2021 | — | $-0.24 | — | — |
Q2 2021 | May 27, 2021 | — | $-0.07 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.05 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.02 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ALVET.PA
What is ALVET.PA's current stock price?
TheraVet S.A. (ALVET.PA) is currently trading at $0.08 per share. The stock has moved +0.00% today.
What is the analyst price target for ALVET.PA?
No analyst price targets are currently available for this stock.
What sector is TheraVet S.A. in?
TheraVet S.A. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the PAR exchange.
What is ALVET.PA's market cap?
TheraVet S.A. has a market capitalization of $0.01 billion, making it a small-cap company.
Does ALVET.PA pay dividends?
No, TheraVet S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALACT.PA
Acticor Biotech SAS
$0.25
Mkt Cap: $0.0B
ALCAR.PA
Carmat S.A.
$0.10
Mkt Cap: $0.0B
ALDEI.PA
Deinove S.A.
$0.03
Mkt Cap: $0.0B
ALHYG.PA
Hybrigenics S.A.
$0.01
Mkt Cap: $0.0B
ALPHE.PA
Pherecydes Pharma S.A.
$2.00
Mkt Cap: $0.0B
ALQGC.PA
Quantum Genomics S.A.
$0.07
Mkt Cap: $0.0B
APM.PA
Aptorum Group Limited
$3.21
Mkt Cap: $0.0B
LYS.PA
Lysogene S.A.
$0.28
Mkt Cap: $0.0B
MLBON.PA
bonyf N.V.
$6.30
Mkt Cap: $0.0B
PHXM.PA
PHAXIAM Therapeutics S.A.
$0.10
Mkt Cap: $0.0B
Explore stocks similar to ALVET.PA for comparison